Clinical Trial Update: Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis [Phase 4]

View source ↗

Summary

This document describes a Phase 4 clinical trial protocol evaluating Acthar Gel (adrenocorticotropic hormone) for moderately to severely active psoriatic arthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Fiechtner, Justus J., M.D., P.C. | Conditions: Psoriatic Arthritis | Phase 4 | Status: UNKNOWN